Tesla Speeds Ahead, While Teva Hits the Skids
On this Market Foolery podcast, host Chris Hill and Motley Fool One's Bill Mann discuss two very different companies with two wildly different places in the market today.
As electric-car innovator Tesla (NASDAQ: TSLA) begins to deliver its long-awaited Model 3, the Fools discuss potential pitfalls -- and whether the company can get by without another stock offering. Teva Pharmaceutical Industries (NYSE: TEVA), meanwhile, faces heavy debt and a challenging market that have cut its market cap in half. So is either a buy at current prices?
A full transcript follows the video.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€15.80
1.610%
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Teva Pharmaceutical Industries Ltd ADR.
With a target price of 18 € there is a slightly positive potential of 13.92% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 15.8 €.
